• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo.体内肿瘤内在因素的会聚鉴定和干扰对癌症免疫的影响。
Cell Syst. 2019 Feb 27;8(2):136-151.e7. doi: 10.1016/j.cels.2019.01.004. Epub 2019 Feb 20.
2
A CRISPR Platform for Targeted In Vivo Screens.用于体内靶向筛选的CRISPR平台。
Methods Mol Biol. 2023;2614:397-409. doi: 10.1007/978-1-0716-2914-7_24.
3
Cancer CRISPR Screens In Vivo.体内癌症CRISPR筛选
Trends Cancer. 2018 May;4(5):349-358. doi: 10.1016/j.trecan.2018.03.002. Epub 2018 Mar 30.
4
Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR-mediated direct in vivo screening.利用 AAV-CRISPR 介导的直接体内筛选技术绘制小鼠肝脏肿瘤抑制因子的功能癌症基因组图谱。
Sci Adv. 2018 Feb 28;4(2):eaao5508. doi: 10.1126/sciadv.aao5508. eCollection 2018 Feb.
5
Spatial CRISPR genomics identifies regulators of the tumor microenvironment.空间 CRISPR 基因组学鉴定肿瘤微环境的调控因子。
Cell. 2022 Mar 31;185(7):1223-1239.e20. doi: 10.1016/j.cell.2022.02.015. Epub 2022 Mar 14.
6
CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes.CRISPR 敲除筛选在鉴定必需基因方面优于 shRNA 和 CRISPRi。
Nat Biotechnol. 2016 Jun;34(6):631-3. doi: 10.1038/nbt.3536. Epub 2016 Apr 25.
7
CRISPR-Cas9 for cancer therapy: Opportunities and challenges.CRISPR-Cas9 用于癌症治疗:机遇与挑战。
Cancer Lett. 2019 Apr 10;447:48-55. doi: 10.1016/j.canlet.2019.01.017. Epub 2019 Jan 23.
8
High-content CRISPR screening in tumor immunology.高内涵 CRISPR 筛选在肿瘤免疫学中的应用。
Front Immunol. 2022 Nov 21;13:1041451. doi: 10.3389/fimmu.2022.1041451. eCollection 2022.
9
Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies.功能 CRISPR 筛选在 T 细胞中揭示了癌症免疫疗法的新机会。
Mol Cancer. 2024 Apr 5;23(1):73. doi: 10.1186/s12943-024-01987-z.
10
Engineered CRISPR Systems for Next Generation Gene Therapies.用于下一代基因治疗的工程化CRISPR系统
ACS Synth Biol. 2017 Sep 15;6(9):1614-1626. doi: 10.1021/acssynbio.7b00011. Epub 2017 Jun 7.

引用本文的文献

1
Crosstalk between KIF1C and PRKAR1A in left atrial myxoma.左心房黏液瘤中 KIF1C 与 PRKAR1A 的串扰。
Commun Biol. 2023 Jul 14;6(1):724. doi: 10.1038/s42003-023-05094-5.
2
Applications of CRISPR technology in cellular immunotherapy.CRISPR 技术在细胞免疫治疗中的应用。
Immunol Rev. 2023 Nov;320(1):199-216. doi: 10.1111/imr.13241. Epub 2023 Jul 14.
3
Opportunities and Challenges of Kava in Lung Cancer Prevention.卡瓦在肺癌预防方面的机遇与挑战。
Int J Mol Sci. 2023 May 31;24(11):9539. doi: 10.3390/ijms24119539.
4
Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function.免疫遗传代谢组学揭示了调节 CAR T 细胞代谢和功能的关键酶。
Cancer Immunol Res. 2023 Aug 3;11(8):1068-1084. doi: 10.1158/2326-6066.CIR-22-0565.
5
Immunogenetic metabolomics revealed key enzymes that modulate CAR-T metabolism and function.免疫遗传代谢组学揭示了调节嵌合抗原受体T细胞(CAR-T)代谢和功能的关键酶。
bioRxiv. 2023 Mar 15:2023.03.14.532663. doi: 10.1101/2023.03.14.532663.
6
Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin prophylaxis of NNK-induced lung carcinogenesis.抑制蛋白激酶 A 的激活作为二氢大麻酚预防 NNK 诱导的肺癌发生的非 DNA 损伤机制先导。
Carcinogenesis. 2022 Aug 30;43(7):659-670. doi: 10.1093/carcin/bgac031.
7
Complex effects of kinase localization revealed by compartment-specific regulation of protein kinase A activity.通过蛋白激酶 A 活性的区室特异性调节揭示激酶定位的复杂效应。
Elife. 2022 Feb 24;11:e66869. doi: 10.7554/eLife.66869.
8
Tumor immunology CRISPR screening: present, past, and future.肿瘤免疫学 CRISPR 筛选:现状、过去和未来。
Trends Cancer. 2022 Mar;8(3):210-225. doi: 10.1016/j.trecan.2021.11.009. Epub 2021 Dec 15.
9
In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target.体内 CRISPR 筛选鉴定出 E3 连接酶 Cop1 作为巨噬细胞浸润的调节剂和癌症免疫治疗靶点。
Cell. 2021 Oct 14;184(21):5357-5374.e22. doi: 10.1016/j.cell.2021.09.006. Epub 2021 Sep 27.
10
Progress and Clinical Application of Single-Cell Transcriptional Sequencing Technology in Cancer Research.单细胞转录组测序技术在癌症研究中的进展与临床应用
Front Oncol. 2021 Feb 3;10:593085. doi: 10.3389/fonc.2020.593085. eCollection 2020.

本文引用的文献

1
Integrating single-cell transcriptomic data across different conditions, technologies, and species.整合不同条件、技术和物种的单细胞转录组数据。
Nat Biotechnol. 2018 Jun;36(5):411-420. doi: 10.1038/nbt.4096. Epub 2018 Apr 2.
2
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.一种主要的染色质调节因子决定肿瘤细胞对T细胞介导杀伤的抗性。
Science. 2018 Feb 16;359(6377):770-775. doi: 10.1126/science.aao1710. Epub 2018 Jan 4.
3
Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion.Carney 综合征中的纤维板层型肝细胞癌:PRKAR1A 缺失而非经典的 DNAJB1-PRKACA 融合。
Hepatology. 2018 Oct;68(4):1441-1447. doi: 10.1002/hep.29719. Epub 2018 May 11.
4
fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma.融合激酶与β-catenin 相互作用,驱动肝再生反应,从而导致纤维板层肝细胞癌。
Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):13076-13084. doi: 10.1073/pnas.1716483114. Epub 2017 Nov 21.
5
Unusual presentations of Carney Complex in patient with a novel PRKAR1A mutation.一名携带新型PRKAR1A突变的患者出现的卡尼综合征的不寻常表现。
Neuro Endocrinol Lett. 2017 Aug;38(4):248-254.
6
Correction of aberrant growth preserves tissue homeostasis.纠正异常生长可维持组织内稳态。
Nature. 2017 Aug 17;548(7667):334-337. doi: 10.1038/nature23304. Epub 2017 Aug 2.
7
Identification of essential genes for cancer immunotherapy.癌症免疫治疗关键基因的鉴定。
Nature. 2017 Aug 31;548(7669):537-542. doi: 10.1038/nature23477. Epub 2017 Aug 7.
8
Novel PRKAR1A mutation in Carney complex with cardiac myxoma.
Pediatr Int. 2017 Jul;59(7):840-841. doi: 10.1111/ped.13302.
9
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.体内CRISPR筛选确定Ptpn2为癌症免疫治疗靶点。
Nature. 2017 Jul 27;547(7664):413-418. doi: 10.1038/nature23270. Epub 2017 Jul 19.
10
Differential analysis of RNA-seq incorporating quantification uncertainty.整合定量不确定性的 RNA-seq 差异分析。
Nat Methods. 2017 Jul;14(7):687-690. doi: 10.1038/nmeth.4324. Epub 2017 Jun 5.

体内肿瘤内在因素的会聚鉴定和干扰对癌症免疫的影响。

Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo.

机构信息

System Biology Institute, Integrated Science & Technology Center, 850 West Campus Drive, West Haven, CT 06516, USA; Department of Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA; Center for Cancer Systems Biology, Integrated Science & Technology Center, 850 West Campus Drive, West Haven, CT 06516, USA; MCGD Program, Yale University, 333 Cedar Street, New Haven, CT 06510, USA.

System Biology Institute, Integrated Science & Technology Center, 850 West Campus Drive, West Haven, CT 06516, USA; Department of Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA; Center for Cancer Systems Biology, Integrated Science & Technology Center, 850 West Campus Drive, West Haven, CT 06516, USA.

出版信息

Cell Syst. 2019 Feb 27;8(2):136-151.e7. doi: 10.1016/j.cels.2019.01.004. Epub 2019 Feb 20.

DOI:10.1016/j.cels.2019.01.004
PMID:30797773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6592847/
Abstract

The genetic makeup of cancer cells directs oncogenesis and influences the tumor microenvironment. In this study, we massively profiled genes that functionally drive tumorigenesis using genome-scale in vivo CRISPR screens in hosts with different levels of immunocompetence. As a convergent hit from these screens, Prkar1a mutant cells are able to robustly outgrow as tumors in fully immunocompetent hosts. Functional interrogation showed that Prkar1a loss greatly altered the transcriptome and proteome involved in inflammatory and immune responses as well as extracellular protein production. Single-cell transcriptomic profiling and flow cytometry analysis mapped the tumor microenvironment of Prkar1a mutant tumors and revealed the transcriptomic alterations in host myeloid cells. Taken together, our data suggest that tumor-intrinsic mutations in Prkar1a lead to drastic alterations in the genetic program of cancer cells, thereby remodeling the tumor microenvironment.

摘要

癌细胞的基因构成指导肿瘤发生,并影响肿瘤微环境。在这项研究中,我们使用具有不同免疫能力的宿主中的全基因组规模体内 CRISPR 筛选,大规模分析了那些在功能上驱动肿瘤发生的基因。作为这些筛选的一个收敛命中,Prkar1a 突变细胞能够在完全免疫能力的宿主中作为肿瘤强劲地生长。功能询问表明,Prkar1a 的缺失极大地改变了参与炎症和免疫反应以及细胞外蛋白产生的转录组和蛋白质组。单细胞转录组谱分析和流式细胞术分析绘制了 Prkar1a 突变肿瘤的肿瘤微环境,并揭示了宿主髓样细胞中的转录组改变。总之,我们的数据表明,Prkar1a 中的肿瘤内在突变导致癌细胞遗传程序的剧烈改变,从而重塑肿瘤微环境。